Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells-Reference-Cited by-同舟云学术

Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells

Published:2023-07-03 Issue:13 Volume:149 Page:11549-11560
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Zhou Yeye,Zhang Bin,Han Jiangqin,Dai Na,Jia Tongtong,Huang Haiwen,Deng Shengming,Sang Shibiao

Funder

National Natural Science Foundation of China

Medical Youth Talent Project of Jiangsu Province

Gusu Health Talent Program

Suzhou People's Livelihood Science and Technology Project

Project of State Key Laboratory of Radiation Medicine and Protection, Soochow University

the Open Foundation of Nuclear Medicine Laboratory of Mianyang Central Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-05038-w.pdf

Reference41 articles.

1. Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 2014(5):4006. https://doi.org/10.1038/ncomms5006

2. Aide N, Fruchart C, Nganoa C, Gac AC, Lasnon C (2020) Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy. Eur Radiol 30:4623–4632. https://doi.org/10.1007/s00330-020-06815-8

3. Barrington SF, Meignan M (2019) Time to prepare for risk adaptation in lymphoma by standardizing measurement of metabolic tumor burden. J Nucl Med 60:1096–1102. https://doi.org/10.2967/jnumed.119.227249

4. Ben Bouallègue F, Tabaa YA, Kafrouni M et al (2017) Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas. Med Phys 44:4608–4619

5. Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imag 42:328–354. https://doi.org/10.1007/s00259-014-2961-x

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis;Frontiers in Immunology;2024-09-02

2. Metabolic tumor volume and the survival of patients with Non-Hodgkin lymphoma treated with chimeric antigen receptor T cell therapy: a meta-analysis;Frontiers in Immunology;2024-08-29

3. Predicting survival, neurotoxicity and response in B-Cell lymphoma patients treated with CAR-T therapy using an imaging features-based model;2024-06-20

4. Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy;European Journal of Nuclear Medicine and Molecular Imaging;2023-12-20